Neuraptive Therapeutics, Inc.

New Filing
CIK: 0001713836·Biotechnology·DELAWARE·Filed: Aug 15, 2018
Total Offering

$100,000

Amount Sold

$100,000

Investors

1

First Sale

Aug 2, 2018

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2017
Non-Accredited Investors
No

Related Persons

NameRole
David M. Jackson
Related Person

Company

Neuraptive Therapeutics, Inc.

2697 TRAILRIDGE DR WEST

LAFAYETTE, CO, 80026

303-736-9657

SEC Filing

0001713836-18-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Neuraptive Therapeutics, Inc. Form D Filing — $100,000 | FilingFlow